celecoxib has been researched along with Angioedema in 8 studies
Angioedema: Swelling involving the deep DERMIS, subcutaneous, or submucosal tissues, representing localized EDEMA. Angioedema often occurs in the face, lips, tongue, and larynx.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Angioedema is potentially life-threating swelling of integument and mucosa that has multiple potential aetiologies with varying mechanisms." | 5.91 | Angioedema without urticaria after recent initiation of celecoxib. ( Abdujelil, I; Anderson, J; Jasti, VV, 2023) |
| " Three subjects with multiple-drug induced urticaria complained of a generalized reaction after challenge (Two due to celecoxib and one due to meloxicam)." | 5.11 | Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients. ( Antonicelli, L; Bilò, MB; Bonadonna, P; Crivellaro, MA; Dama, AR; Schiappoli, M; Senna, G, 2004) |
| "Patients with NSAID-induced urticaria or angioedema were challenged in a double-masked, placebo-controlled design protocol with etoricoxib (120 mg) and celecoxib (200 mg)." | 5.11 | Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema. ( Caballero-Fonseca, F; Capriles-Hulett, A; Sánchez-Borges, M, 2005) |
| "Celecoxib (CE) is a novel drug, with high selectivity and affinity for COX-2 enzyme." | 2.71 | Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs. ( D'Amato, G; D'Amato, M; Liccardi, G; Piccolo, A; Piscitelli, E; Salzillo, A; Senna, G, 2005) |
| "Angioedema is potentially life-threating swelling of integument and mucosa that has multiple potential aetiologies with varying mechanisms." | 1.91 | Angioedema without urticaria after recent initiation of celecoxib. ( Abdujelil, I; Anderson, J; Jasti, VV, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Jasti, VV | 1 |
| Anderson, J | 1 |
| Abdujelil, I | 1 |
| Kasemsarn, P | 1 |
| Kulthanan, K | 1 |
| Tuchinda, P | 1 |
| Dhana, N | 1 |
| Jongjarearnprasert, K | 1 |
| García-Rodríguez, RM | 1 |
| Hinojosa, M | 1 |
| Camacho-Garrido, E | 1 |
| Berges Gimeno, P | 1 |
| Martín García, C | 1 |
| Senna, G | 2 |
| Bilò, MB | 1 |
| Antonicelli, L | 1 |
| Schiappoli, M | 1 |
| Crivellaro, MA | 1 |
| Bonadonna, P | 1 |
| Dama, AR | 1 |
| Liccardi, G | 2 |
| D'Amato, G | 2 |
| Canonica, GW | 1 |
| Lobefalo, G | 1 |
| Noschese, P | 1 |
| Piccolo, A | 2 |
| Salzillo, A | 2 |
| Passalacqua, G | 1 |
| Piscitelli, E | 1 |
| D'Amato, M | 1 |
| Sánchez-Borges, M | 1 |
| Caballero-Fonseca, F | 1 |
| Capriles-Hulett, A | 1 |
| Kelkar, PS | 1 |
| Butterfield, JH | 1 |
| Teaford, HG | 1 |
4 trials available for celecoxib and Angioedema
| Article | Year |
|---|---|
Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.
Topics: Adolescent; Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Celec | 2004 |
Safety of celecoxib in patients with adverse reactions to nimesulide.
Topics: Adolescent; Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Drug Hypers | 2005 |
Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs.
Topics: Acetaminophen; Adolescent; Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Celecox | 2005 |
Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema.
Topics: Adolescent; Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygen | 2005 |
4 other studies available for celecoxib and Angioedema
| Article | Year |
|---|---|
Angioedema without urticaria after recent initiation of celecoxib.
Topics: Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Humans; Skin; Urticaria | 2023 |
Cutaneous reactions to non-steroidal anti-inflammatory drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Cel | 2011 |
Celecoxib, safe in NSAID intolerance.
Topics: Administration, Oral; Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; C | 2002 |
Urticaria and angioedema from cyclooxygenase-2 inhibitors.
Topics: Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibito | 2001 |